Nuvation Bio (NUVB) Competitors $3.14 0.00 (0.00%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$3.13 -0.01 (-0.32%) As of 09/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB vs. TGTX, MRUS, CRSP, PTCT, KRYS, PCVX, ACAD, ACLX, ADMA, and ARWRShould you be buying Nuvation Bio stock or one of its competitors? The main competitors of Nuvation Bio include TG Therapeutics (TGTX), Merus (MRUS), CRISPR Therapeutics (CRSP), PTC Therapeutics (PTCT), Krystal Biotech (KRYS), Vaxcyte (PCVX), ACADIA Pharmaceuticals (ACAD), Arcellx (ACLX), ADMA Biologics (ADMA), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry. Nuvation Bio vs. Its Competitors TG Therapeutics Merus CRISPR Therapeutics PTC Therapeutics Krystal Biotech Vaxcyte ACADIA Pharmaceuticals Arcellx ADMA Biologics Arrowhead Pharmaceuticals Nuvation Bio (NYSE:NUVB) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Which has preferable earnings & valuation, NUVB or TGTX? TG Therapeutics has higher revenue and earnings than Nuvation Bio. Nuvation Bio is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuvation Bio$7.87M136.56-$567.94M-$0.63-4.98TG Therapeutics$454.07M11.09$23.38M$0.3785.81 Do institutionals & insiders hold more shares of NUVB or TGTX? 61.7% of Nuvation Bio shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 29.9% of Nuvation Bio shares are held by insiders. Comparatively, 10.6% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NUVB or TGTX more profitable? TG Therapeutics has a net margin of 13.31% compared to Nuvation Bio's net margin of -1,413.43%. TG Therapeutics' return on equity of 26.05% beat Nuvation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Nuvation Bio-1,413.43% -46.14% -36.04% TG Therapeutics 13.31%26.05%9.58% Do analysts prefer NUVB or TGTX? Nuvation Bio currently has a consensus target price of $7.50, indicating a potential upside of 138.85%. TG Therapeutics has a consensus target price of $46.25, indicating a potential upside of 45.67%. Given Nuvation Bio's stronger consensus rating and higher probable upside, analysts plainly believe Nuvation Bio is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuvation Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more risk and volatility, NUVB or TGTX? Nuvation Bio has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500. Does the media refer more to NUVB or TGTX? In the previous week, TG Therapeutics had 4 more articles in the media than Nuvation Bio. MarketBeat recorded 9 mentions for TG Therapeutics and 5 mentions for Nuvation Bio. TG Therapeutics' average media sentiment score of 1.19 beat Nuvation Bio's score of 0.63 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuvation Bio 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryTG Therapeutics beats Nuvation Bio on 10 of the 17 factors compared between the two stocks. Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUVB vs. The Competition Export to ExcelMetricNuvation BioMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.07B$3.15B$5.80B$21.53BDividend YieldN/A2.32%5.73%3.50%P/E Ratio-4.9821.2474.8629.84Price / Sales136.56472.01544.6070.94Price / CashN/A44.4425.8118.13Price / Book2.299.6413.254.65Net Income-$567.94M-$53.20M$3.29B$999.94M7 Day Performance-6.27%0.07%0.07%1.08%1 Month Performance14.18%4.27%4.59%4.53%1 Year Performance2.28%9.62%72.95%14.39% Nuvation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUVBNuvation Bio2.6371 of 5 stars$3.14flat$7.50+138.9%+3.0%$1.07B$7.87M-4.9860Gap DownTGTXTG Therapeutics4.3007 of 5 stars$32.38+0.5%$46.25+42.8%+33.8%$5.11B$329M87.51290Positive NewsMRUSMerus2.7953 of 5 stars$67.19-0.4%$88.75+32.1%+35.8%$5.10B$36.13M-12.2237Positive NewsCRSPCRISPR Therapeutics3.2359 of 5 stars$54.10-1.4%$71.60+32.3%+18.2%$4.99B$37.31M-9.96460PTCTPTC Therapeutics3.8027 of 5 stars$56.95-0.5%$69.00+21.2%+73.5%$4.55B$806.78M8.171,410Insider TradeKRYSKrystal Biotech4.9585 of 5 stars$145.20-3.4%$210.38+44.9%-22.8%$4.35B$290.52M29.51210Positive NewsAnalyst ForecastPCVXVaxcyte2.347 of 5 stars$32.41-1.8%$130.00+301.1%-73.3%$4.29BN/A0.00160Positive NewsACADACADIA Pharmaceuticals4.2107 of 5 stars$25.39+0.5%$28.88+13.7%+51.2%$4.26B$957.80M19.09510ACLXArcellx2.2705 of 5 stars$71.11-2.1%$114.31+60.7%-2.2%$4.03B$107.94M0.0080Positive NewsADMAADMA Biologics3.686 of 5 stars$16.42-2.7%$27.67+68.5%-15.4%$4.03B$426.45M19.09530Positive NewsARWRArrowhead Pharmaceuticals4.1521 of 5 stars$27.17-6.6%$43.14+58.8%+33.4%$4.02B$3.55M-21.23400 Related Companies and Tools Related Companies TG Therapeutics Alternatives Merus Alternatives CRISPR Therapeutics Alternatives PTC Therapeutics Alternatives Krystal Biotech Alternatives Vaxcyte Alternatives ACADIA Pharmaceuticals Alternatives Arcellx Alternatives ADMA Biologics Alternatives Arrowhead Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUVB) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUVB Stock Alerts